^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
ECP-1014
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Euclises Pharma
Drug class:
COX2 inhibitor
Related drugs:
Phase 1
Euclises Pharmaceuticals, Inc.
Recruiting
Last update posted :
02/16/2023
Initiation :
05/01/2023
Primary completion :
09/01/2023
Completion :
12/01/2023
PTGS2
|
PTGS2 expression
|
ECP-1014
Share
